Center for Medical Biomics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
PLoS One. 2011 Mar 23;6(3):e17154. doi: 10.1371/journal.pone.0017154.
Obesity promotes inflammation in adipose tissue (AT) and this is implicated in pathophysiological complications such as insulin resistance, type 2 diabetes and cardiovascular disease. Although based on the classical hypothesis, necrotic AT adipocytes (ATA) in obese state activate AT macrophages (ATM) that then lead to a sustained chronic inflammation in AT, the link between human adipocytes and the source of inflammation in AT has not been in-depth and systematically studied. So we decided as a new hypothesis to investigate human primary adipocytes alone to see whether they are able to prime inflammation in AT.
Using mRNA expression, human preadipocytes and adipocytes express the cytokines/chemokines and their receptors, MHC II molecule genes and 14 acute phase reactants including C-reactive protein. Using multiplex ELISA revealed the expression of 50 cytokine/chemokine proteins by human adipocytes. Upon lipopolysaccharide stimulation, most of these adipocyte-associated cytokines/chemokines and immune cell modulating receptors were up-regulated and a few down-regulated such as (ICAM-1, VCAM-1, MCP-1, IP-10, IL-6, IL-8, TNF-α and TNF-β highly up-regulated and IL-2, IL-7, IL-10, IL-13 and VEGF down-regulated. In migration assay, human adipocyte-derived chemokines attracted significantly more CD4+ T cells than controls and the number of migrated CD4+ cells was doubled after treating the adipocytes with LPS. Neutralizing MCP-1 effect produced by adipocytes reduced CD4+ migration by approximately 30%.
Human adipocytes express many cytokines/chemokines that are biologically functional. They are able to induce inflammation and activate CD4+ cells independent of macrophages. This suggests that the primary event in the sequence leading to chronic inflammation in AT is metabolic dysfunction in adipocytes, followed by production of immunological mediators by these adipocytes, which is then exacerbated by activated ATM, activation and recruitment of immune cells. This study provides novel knowledge about the prime of inflammation in human obese adipose tissue, opening a new avenue of investigations towards obesity-associated type 2 diabetes.
肥胖会促进脂肪组织(AT)中的炎症,这与胰岛素抵抗、2 型糖尿病和心血管疾病等病理生理并发症有关。尽管基于经典假说,肥胖状态下的坏死脂肪细胞(ATA)会激活脂肪组织巨噬细胞(ATM),从而导致 AT 持续慢性炎症,但人类脂肪细胞与 AT 炎症源之间的联系尚未得到深入和系统的研究。因此,我们提出了一个新的假说,即单独研究人类原代脂肪细胞,以观察它们是否能够引发 AT 的炎症。
使用 mRNA 表达谱,人类前脂肪细胞和脂肪细胞表达细胞因子/趋化因子及其受体、MHC II 分子基因和 14 种急性期反应物,包括 C 反应蛋白。使用多重 ELISA 法检测到脂肪细胞表达 50 种细胞因子/趋化因子蛋白。在脂多糖刺激下,大多数与脂肪细胞相关的细胞因子/趋化因子和免疫细胞调节受体上调,少数下调,如(ICAM-1、VCAM-1、MCP-1、IP-10、IL-6、IL-8、TNF-α和 TNF-β 高度上调,IL-2、IL-7、IL-10、IL-13 和 VEGF 下调。在迁移实验中,与对照组相比,人脂肪细胞衍生的趋化因子明显吸引了更多的 CD4+T 细胞,并且在用 LPS 处理脂肪细胞后,迁移的 CD4+细胞数量增加了一倍。脂肪细胞产生的 MCP-1 中和作用使 CD4+细胞迁移减少了约 30%。
人类脂肪细胞表达许多具有生物学功能的细胞因子/趋化因子。它们能够在不依赖巨噬细胞的情况下诱导炎症和激活 CD4+细胞。这表明导致 AT 慢性炎症的序列中的初始事件是脂肪细胞的代谢功能障碍,随后这些脂肪细胞产生免疫介质,然后被激活的 ATM 加剧,免疫细胞的激活和募集。这项研究提供了关于人类肥胖脂肪组织炎症引发的新认识,为肥胖相关 2 型糖尿病的研究开辟了新途径。